Team
Portfolio
News
Contact

Back to Portfolio

Kartos Therapeutics

Website LinkedIn

Clinical stage company developing a MDM2 inhibitor- Navtemadlin- for the treatment of myelofibrosis

Therapeutic Area
Oncology: Stage
Clinical: CEO
Jesse McGreivy, MD: Geography
Redwood City, USA

© 2024 SR One Capital ManagementLinkedIn

For media enquires, please email sronemedia@sambrown.com

California

929 Main Street
Suite 200
Redwood City, CA 94063
United States

Pennsylvania

985 Old Eagle School Road
Suite 511
Wayne, PA 19087
United States

London

29 Farm Street
London
W1J 5RL
United Kingdom

Privacy Policy California Privacy Policy EU Privacy Policy Terms & Conditions Regulatory Disclosures